Bovine Serum Albumin-Loaded Chitosan Particles: An Evaluation of Effective Parameters on Fabrication, Characteristics, and in Vitro Release in the Presence of Non-Covalent Interactions
Source abstract
Abstract
BSA-loaded chitosan particles were produced using a W/O microemulsion composed of isooctane as a solvent, 1-hexanol as a co-solvent, and cetyltrimethylammonium bromide (CTAB) as a surfactant. The purpose of the current study was to investigate the effects of non-covalent interactions of BSA as a protein, chitosan as a polysaccharide, and CTAB on fabrication of BSA-loaded chitosan particles, characteristics and release profile, and the presence in the W/O microemulsion was investigated using a turbidimeter. The interactions caused an increase in the average size of the particles ranging from 1.61 to 2.05 µm and were effective on the release behaviors.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Polymer Surface Interaction Studies · Proteins in Food Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (38)
Show source-provided references
1. 10.1080/1745808080251690910.1080/17458080802516909 ↗
2. 10.1002/adma.20070266310.1002/adma.200702663 ↗
3. 10.1016/j.jconrel.2004.08.01010.1016/j.jconrel.2004.08.010 ↗
4. 10.1002/app.2879210.1002/app.28792 ↗
5. 10.1016/j.reactfunctpolym.2005.06.00910.1016/j.reactfunctpolym.2005.06.009 ↗
6. 10.1080/0091403980804106210.1080/00914039808041062 ↗
7. 10.1016/S0169-409X(01)00197-110.1016/S0169-409X(01)00197-1 ↗
8. 10.1016/j.carbpol.2007.07.01010.1016/j.carbpol.2007.07.010 ↗
9. 10.1016/j.ijbiomac.2009.12.01810.1016/j.ijbiomac.2009.12.018 ↗
10. 10.1016/j.colsurfb.2007.04.00910.1016/j.colsurfb.2007.04.009 ↗
11. 10.1021/ja052805i10.1021/ja052805i ↗
12. 10.1021/jp053057m10.1021/jp053057m ↗
13. 10.1016/S0168-3659(01)00342-X10.1016/S0168-3659(01)00342-X ↗
14. 10.1016/j.reactfunctpolym.2006.05.00610.1016/j.reactfunctpolym.2006.05.006 ↗
15. 10.1016/j.cpart.2007.08.00210.1016/j.cpart.2007.08.002 ↗
16. 10.1016/j.biotechadv.2006.07.00310.1016/j.biotechadv.2006.07.003 ↗
17. 10.1016/j.ejpb.2007.11.00810.1016/j.ejpb.2007.11.008 ↗
18. 10.1007/s11434-007-0127-y10.1007/s11434-007-0127-y ↗
19. 10.1080/0360255090315906910.1080/03602550903159069 ↗
20. 10.1016/j.ijpharm.2010.03.06310.1016/j.ijpharm.2010.03.063 ↗
21. 10.1016/j.ijpharm.2003.12.02610.1016/j.ijpharm.2003.12.026 ↗
22. 10.1080/03602559.2010.48207610.1080/03602559.2010.482076 ↗
23. 10.1016/S0142-9612(99)00263-X10.1016/S0142-9612(99)00263-X ↗
24. 10.1016/0003-2697(76)90527-310.1016/0003-2697(76)90527-3 ↗
25. 10.1016/j.carbpol.2007.07.00910.1016/j.carbpol.2007.07.009 ↗
26. Liu Y. · Iran. Polym. J. · 2009 · 18 · 339
27. 10.1016/S1359-0294(00)00054-610.1016/S1359-0294(00)00054-6 ↗
28. 10.1016/j.carbpol.2003.05.00410.1016/j.carbpol.2003.05.004 ↗
29. 10.1016/S1369-703X(97)00019-310.1016/S1369-703X(97)00019-3 ↗
30. 10.1016/j.cis.2006.11.00910.1016/j.cis.2006.11.009 ↗
31. 10.1016/j.ijpharm.2007.08.05710.1016/j.ijpharm.2007.08.057 ↗
32. 10.1016/S1369-703X(99)00024-810.1016/S1369-703X(99)00024-8 ↗
33. 10.1016/j.seppur.2006.10.00110.1016/j.seppur.2006.10.001 ↗
34. 10.1016/S0169-409X(00)00103-410.1016/S0169-409X(00)00103-4 ↗
35. 10.1016/j.jcis.2008.01.04810.1016/j.jcis.2008.01.048 ↗
36. 10.1016/j.reactfunctpolym.2006.01.01410.1016/j.reactfunctpolym.2006.01.014 ↗
37. 10.1080/0091403050044024510.1080/00914030500440245 ↗
38. 10.1016/j.micromeso.2008.07.00210.1016/j.micromeso.2008.07.002 ↗